Dr. Stephen T. Ong, MD

Dr. Ong practices at Greater Washington Medicenter T/A Healthcare of Greater Washingto in Oxon Hill, Maryland.

Dr. Ong's NPI, 1851479281, was assigned on November 2, 2006. Dr. Ong holds Maryland license D014760.

Dr. Ong's primary practice is Greater Washington Medicenter T/A Healthcare of Greater Washingto, at 6357 Oxon Hill Rd, Oxon Hill, MD 20745 in Prince Georges County. The practice phone is (301) 839-2820.

Dr. Ong's primary practice is Greater Washington Medicenter T/A Healthcare of Greater Washingto in Oxon Hill, Maryland. The medical group on file is Healthcare of Greater Washington. Dmand AI also links Dr. Ong to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ong practices. Vendor and product names are available with a free account.

Family medicine is Dr. Ong's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Ong's licenses on file in 2 states: Maryland and District of Columbia.

CMS data shows 1,241 Medicare services from Dr. Ong across 10 procedure codes in 2024, for 197 Medicare patients. Medicare paid $90,866 for them. Every service was in an office.

CMS counts 197 Medicare patients who saw Dr. Ong in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ong's median patient age at 65, with 46% women.

In 2024, Dr. Ong wrote 2,489 Medicare Part D claims for 192 patients. 88% of them were for generic drugs. CMS names the drug for 2,018 of them, across 54 drugs with 11 or more claims each, at $209,355 in total drug cost. In 2023, CMS named 1,014 claims across 41 drugs.

Dr. Ong accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Ong to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Hyperlipidemias and Alzheimer Disease. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Ong that name 7 trials.

CMS Open Payments shows 1,081 general payments to Dr. Ong from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Novo Nordisk Inc paid the most, $7,099. It also lists 57 research payments totaling $254,825 from 2016 to 2024, naming 7 clinical trials.